3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Hematologic Neoplasms
6
Leukemia, Myeloid, Acute
5
Lymphoma
3
Rhabdoid Tumor
2
Osteosarcoma
2
Neuroblastoma
2
Myelodysplastic Syndromes
2
Multiple Myeloma
2
Wilms Tumor
1
Teratoma
1
Sarcoma, Ewing
1
Sarcoma, Clear Cell
1
Sarcoma
1
Rhabdomyosarcoma
1
Recurrence
1
Pyloric Stenosis, Hypertrophic
1
Prostatic Neoplasms
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Pinealoma
1
Neurofibrosarcoma
1
Neuroectodermal Tumors, Primitive
1
Neoplasms, Germ Cell and Embryonal
1
Metabolic Diseases
1
Melanoma
1
Medulloblastoma
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Non-Hodgkin
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Biphenotypic, Acute
1
Interventions
Cyclophosphamide
10
fludarabine
6
Tacrolimus
5
Mycophenolic Acid
5
Melphalan
4
ruxolitinib
3
Whole-Body Irradiation
3
Thiotepa
3
Busulfan
3
thymoglobulin
2
fludarabine phosphate
2
Stem Cell Transplantation
2
Specimen Handling
2
Clofarabine
2
Biopsy
2
vedolizumab
1
belumosudil
1
Tomography, Optical Coherence
1
Sirolimus
1
Radiotherapy
1
Radiation
1
Prednisone
1
Methotrexate
1
Mesna
1
Low-Level Light Therapy
1
LDP-02
1
Immunoglobulin G
1
Hematopoietic Stem Cell Transplantation
1
Fecal Microbiota Transplantation
1
Emapalumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Graft vs Host Disease
×
Mesna
×
Clear all
NCT04678401
2025-10-20
IS-free Treg HaploHCT
Dana-Farber Cancer Institute
Phase 1
Recruiting
30 enrolled